Biomarin Pharmaceutical Inc (BMRN)
Return on equity (ROE)
| Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | 520,417 | 657,241 | 523,883 | 426,859 | 322,291 | 256,589 | 205,455 | 167,645 | 147,021 | 99,991 | 71,615 | 141,561 | 83,912 | 54,070 | 39,347 | -64,080 | 15,917 | 837,214 | 795,090 | 859,100 |
| Total stockholders’ equity | US$ in thousands | 6,056,710 | 6,027,110 | 5,793,460 | 5,657,990 | 5,413,400 | 5,286,300 | 5,073,820 | 4,951,550 | 4,896,900 | 4,782,830 | 4,659,040 | 4,603,160 | 4,568,510 | 4,504,810 | 4,391,320 | 4,270,740 | 4,266,150 | 4,241,570 | 4,162,010 | 4,106,000 |
| ROE | 8.59% | 10.90% | 9.04% | 7.54% | 5.95% | 4.85% | 4.05% | 3.39% | 3.00% | 2.09% | 1.54% | 3.08% | 1.84% | 1.20% | 0.90% | -1.50% | 0.37% | 19.74% | 19.10% | 20.92% |
September 30, 2025 calculation
ROE = Net income (ttm) ÷ Total stockholders’ equity
= $520,417K ÷ $6,056,710K
= 8.59%
Peer comparison
Sep 30, 2025
Company name
Symbol
ROE
Biomarin Pharmaceutical Inc
BMRN
8.59%
Arrowhead Pharmaceuticals Inc
ARWR
-0.35%
Regeneron Pharmaceuticals Inc
REGN
14.79%